Arber DA, Orazi A, Hasserjian RP et al (2022) International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200–1228

Article  PubMed  CAS  Google Scholar 

Kobayashi S, Kobayashi A, Osawa Y et al (2017) Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation. Leukemia 31(4):1020–1022

Article  PubMed  CAS  Google Scholar 

Galera P, Hsu AP, Wang W et al (2018) Donor-derived MDS/AML in families with germline GATA2 mutation. Blood 132(18):1994–1998

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xiao H, Shi J, Luo Y et al (2011) First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood 117(19):5257–5260

Article  PubMed  CAS  Google Scholar 

Owen CJ, Toze CL, Koochin A et al (2008) Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood 112(12):4639–4645

Article  PubMed  CAS  Google Scholar 

Keeshan K, Santilli G, Corradini F, Perrotti D, Calabretta B (2003) Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Blood 102(4):1267–1275

Article  PubMed  CAS  Google Scholar 

Pabst T, Mueller BU (2009) Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin Cancer Res 15(17):5303–5307

Article  PubMed  CAS  Google Scholar 

Tawana K, Wang J, Renneville A et al (2015) Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood 126(10):1214–1223

Article  PubMed  CAS  Google Scholar 

Pathak A, Seipel K, Pemov A et al (2016) Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family. Haematologica 101(7):846–852

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pabst T, Eyholzer M, Haefliger S, Schardt J, Mueller BU (2008) Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. J Clin Oncol 26(31):5088–5093

Article  PubMed  CAS  Google Scholar 

Linder P (2006) Dead-box proteins: a family affair—active and passive players in RNP-remodeling. Nucleic Acids Res 34(15):4168–4180

Article  PubMed  PubMed Central  CAS  Google Scholar 

Polprasert C, Schulze I, Sekeres MA et al (2015) Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell 27(5):658–670

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lewinsohn M, Brown AL, Weinel LM et al (2016) Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. Blood 127(8):1017–1023

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guha T, Malkin D (2017) Inherited TP53 mutations and the Li-Fraumeni syndrome. Cold Spring Harb Perspect Med 7(4).

Holmfeldt L, Wei L, Diaz-Flores E et al (2013) The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 45(3):242–252

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345–2352

Article  PubMed  CAS  Google Scholar 

Li FP, Fraumeni JF Jr, Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48(18):5358–5362

PubMed  CAS  Google Scholar 

Law JC, Strong LC, Chidambaram A, Ferrell RE (1991) A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res 51(23 Pt 1):6385–6387

PubMed  CAS  Google Scholar 

Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20(34):4621–4628

Article  PubMed  CAS  Google Scholar 

Talwalkar SS, Yin CC, Naeem RC, Hicks MJ, Strong LC, Abruzzo LV (2010) Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome. Arch Pathol Lab Med 134(7):1010–1015

Article  PubMed  Google Scholar 

Godley LA, Larson RA (2008) Therapy-related myeloid leukemia. Semin Oncol 35(4):418–429

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kanagal-Shamanna R, Loghavi S, DiNardo CD et al (2017) Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation. Haematologica 102(10):1661–1670

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bluteau D, Balduini A, Balayn N et al (2014) Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest 124(2):580–591

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zaninetti C, Santini V, Tiniakou M, Barozzi S, Savoia A, Pecci A (2017) Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases J. Thromb Haemost 15(12):2388–2392

Article  CAS  Google Scholar 

Poggi M, Canault M, Favier M et al (2017) Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors. Haematologica 102(2):282–294

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bluteau D, Glembotsky AC, Raimbault A et al (2012) Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression. Blood 120(13):2708–2718

Article  PubMed  CAS  Google Scholar 

Song WJ, Sullivan MG, Legare RD et al (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23(2):166–175

Article  PubMed  CAS  Google Scholar 

Schlegelberger B, Heller PG (2017) RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM). Semin Hematol 54(2):75–80

Article  PubMed  Google Scholar 

Pippucci T, Savoia A, Perrotta S et al (2011) Mutations in the 5′ UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet 88(1):115–120

Article  PubMed  PubMed Central  CAS  Google Scholar 

Noris P, Perrotta S, Seri M et al (2011) Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood 117(24):6673–6680

Article  PubMed  CAS  Google Scholar 

Noris P, Favier R, Alessi MC et al (2013) ANKRD26-related thrombocytopenia and myeloid malignancies. Blood 122(11):1987–1989

Article  PubMed  CAS  Google Scholar 

Zhang MY, Churpek JE, Keel SB et al (2015) Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet 47(2):180–185

Article  PubMed  PubMed Central  CAS  Google Scholar 

Noetzli L, Lo RW, Lee-Sherick AB et al (2015) Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet 47(5):535–538

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hsu AP, Sampaio EP, Khan J et al (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118(10):2653–2655

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dickinson RE, Griffin H, Bigley V et al (2011) Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte B and NK lymphoid deficiency. Blood 118(10):2656–2658

Article  PubMed  CAS  Google Scholar 

Hahn CN, Chong CE, Carmichael CL et al (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43(10):1012–1017

Article  PubMed  PubMed Central  CAS